60 Degrees Pharmaceuticals, Inc. (SXTP)

0.8701 -0.01 (-0.66%) USD  |  NASDAQ  |  Oct 23, 16:00
0.8758 +0.01 (+0.66%) After-Hours: 20:00
More

60 Degrees Pharmaceuticals EPS Diluted (Quarterly) : -0.903 for June 30, 2026

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -0.903
March 31, 2026 -1.280
December 31, 2025 -1.348
September 30, 2025 -2.659
June 30, 2025 -5.005
March 31, 2025 -1.562
December 31, 2024 -15.38
September 30, 2024 -0.9299
June 30, 2024 -84.50
Date Value
March 31, 2024 7.318
December 31, 2023 -4.290
September 30, 2023 8.640
June 30, 2023 -6.891
March 31, 2023 -5.370
September 30, 2022 -59.79
March 31, 2022 -1.884
December 31, 2021 -2.811

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Harrow, Inc. -0.4624
ANI Pharmaceuticals, Inc. 1.052
Corcept Therapeutics, Inc. 0.356
Veru, Inc. -0.3032
Johnson & Johnson 0.0858

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -2.263M
Revenue (Quarterly) 0.2079M
Total Expenses (Quarterly) 2.470M
Enterprise Value 10.92M
Gross Profit Margin (Quarterly) 27.32%
Profit Margin (Quarterly) -1.09K%
Earnings Yield -711.4%
Normalized Earnings Yield -738.39